investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.
Investigator from University of Navarra
0 Collaborator(s)
Funding source
European Commission (Belgium)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Investigator from University of Navarra
University of Navarra
Pamplona, Spain
Related projects
Norman Wolmark
NRG Oncology Network Group Operations Center
Liver and intrahepatic bile ducts
Radiation Oncology
Surgery / Surgical oncology
Jian-Min Yuan
Prospective Studies of Cancer Etiology and Prevention in Shanghai and Singapore
Liver and intrahepatic bile ducts
Pathology
Charles D Blanke
SWOG Network Group Operations Center of the NCTN
Liver and intrahepatic bile ducts
Marshall Hicks
Pilot Program for Early Detection of Hepatocellular Carcinoma (HCC) in Underserved Communities: Development and Validation of Prognostic Markers
Liver and intrahepatic bile ducts
Hashem B El-Serag
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
Liver and intrahepatic bile ducts
Xin Wei Wang
Molecular signatures for Liver cancer diagnosis and treatment stratification
Liver and intrahepatic bile ducts
Pathology
Ramou Njie
Gambia Hepatitis Intervention Study
Liver and intrahepatic bile ducts
Pathology
Yvonne N Flores
Genetic and Environmental Risk of Liver Disease/Cancer Among Mexicans
Liver and intrahepatic bile ducts
Pathology
Michael A Gelman
Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism
Liver and intrahepatic bile ducts
